The proteasome inhibitor carfilzomib (Cfz) induces cardiotoxicity in vivo: molecular mechanisms and the cardioprotective effect of metformin (Met). (July 2018) - Kremastiotis, G.; Efentakis, P.; Varela, A.; Davos, C.H.; Tsoumani, M.; Papanagnou, E.D.; Trougakos, I.P.; Kastritis, E.; Kanaki, Z.; Iliodromitis, E.K.; Klinakis, A.; Dimopoulos, M.A.; et al.